Aortic Stenosis: A Contemporary Review

被引:15
作者
Sawaya, Fadi [1 ]
Liff, David [1 ]
Stewart, Jim [1 ]
Lerakis, Stamatios [1 ]
Babaliaros, Vasilis [1 ]
机构
[1] Emory Univ Hosp, Dept Internal Med, Div Cardiol, Atlanta, GA 30322 USA
关键词
Aortic stenosis; Aortic valve; Transcatheter; Percutaneous; VALVE-REPLACEMENT; CLINICAL FACTORS; TRANSCATHETER; PROGRESSION; DISEASE; IMPLANTATION; VALVULOPLASTY; ROSUVASTATIN; PATHOGENESIS; ASSOCIATION;
D O I
10.1097/MAJ.0b013e3182539d70
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aortic stenosis (AS) is the most common valvular disease in the western world affecting mainly individuals older than 60 years. It is recognized as an indolent disease characterized by years to decades of slow progression followed by rapid clinical deterioration and high mortality once symptoms develop. Medical therapies for AS remain ineffective with surgical aortic valve replacement (AVR) remaining the only proven effective long-term treatment. The advancement in transcatheter AVR has revolutionized the treatment of inoperable severe AS and holds promise for future widespread use as more long-term experience is established. The authors review the natural history of AS presentation with a special emphasis on management of severe AS and advancement in transcatheter AVR.
引用
收藏
页码:490 / 496
页数:7
相关论文
共 51 条
[1]  
American College of Cardiology, 2006, J Am Coll Cardiol, V48, pe1, DOI 10.1016/j.jacc.2006.05.021
[2]   Front Stroke, Back Stroke The "Emerging" Interest of Stroke in Transcatheter Aortic Valve Implantation [J].
Babaliaros, Vasilis C. .
JACC-CARDIOVASCULAR INTERVENTIONS, 2010, 3 (11) :1139-1140
[3]   Immediate and Long-Term Echocardiographic Findings after Transcatheter Aortic Valve Implantation for the Treatment of Aortic Stenosis: The Cribier-Edwards/Edwards-Sapien Valve Experience [J].
Bauer, Fabrice ;
Lemercier, Mathieu ;
Zajarias, Alan ;
Tron, Christophe ;
Eltchaninoff, Helene ;
Cribier, Alain .
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY, 2010, 23 (04) :370-376
[4]   Association of cholesterol levels, hydroxymethylglutaryl coenzyme-A reductase inhibitor treatment, and progression of aortic stenosis in the community [J].
Bellamy, MF ;
Pellikka, PA ;
Klarich, KW ;
Tajik, AJ ;
Enriquez-Sarano, M .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 40 (10) :1723-1730
[5]   Isolated aortic valve replacement in North America comprising 108,687 patients in 10 years: Changes in risks, valve types, and outcomes in the Society of Thoracic Surgeons National Database [J].
Brown, James M. ;
O'Brien, Sean M. ;
Wu, Changfu ;
Sikora, Jo Ann H. ;
Griffith, Bartley P. ;
Gammie, James S. .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2009, 137 (01) :82-90
[6]   Effect of Lipid Lowering With Rosuvastatin on Progression of Aortic Stenosis Results of the Aortic Stenosis Progression Observation: Measuring Effects of Rosuvastatin (ASTRONOMER) Trial [J].
Chan, Kwan Leung ;
Teo, Koon ;
Dumesnil, Jean G. ;
Ni, Andy ;
Tam, James .
CIRCULATION, 2010, 121 (02) :306-U247
[7]   Comparison of the Hemodynamic Performance of Percutaneous and Surgical Bioprostheses for the Treatment of Severe Aortic Stenosis [J].
Clavel, Marie-Annick ;
Webb, John G. ;
Pibarot, Philippe ;
Altwegg, Lukas ;
Dumont, Eric ;
Thompson, Chris ;
De Larochelliere, Robert ;
Doyle, Daniel ;
Masson, Jean-Bernard ;
Bergeron, Sebastien ;
Bertrand, Olivier F. ;
Rodes-Cabau, Josep .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (20) :1883-1891
[8]   A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis [J].
Cowell, SJ ;
Newby, DE ;
Prescott, RJ ;
Bloomfield, P ;
Reid, J ;
Northridge, DB ;
Boon, NA .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (23) :2389-2397
[9]   Spectrum of calcific aortic valve disease - Pathogenesis, disease progression, and treatment strategies [J].
Freeman, RV ;
Otto, CM .
CIRCULATION, 2005, 111 (24) :3316-3326
[10]   Why angina in aortic stenosis with normal coronary arteriograms? [J].
Gould, KL ;
Carabello, BA .
CIRCULATION, 2003, 107 (25) :3121-3123